Fractyl Health, Inc.
Status: Publicly traded
Direct answer
Fractyl Health, Inc. is publicly traded on NASDAQ under the ticker GUTS.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus...
Can you invest in Fractyl Health, Inc.?
Yes. Fractyl Health, Inc. is publicly traded on NASDAQ under the ticker GUTS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Fractyl Health, Inc.
Detailed equity research is provided by MarketSnap.